AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Investor Webinar Recording, page-4

  1. 691 Posts.
    lightbulb Created with Sketch. 160
    the webinar seems to be consistent with the presentation given by Auscann recently. Ido made is very clear that they won't be commercialising any novel drugs as this takes 10-15 years and $200m dollars. So this does leave the question if his plan is purely to create drug delivery technology of a "hard shell capsule", does this have any value?
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.